Annual Working Capital
$739.83 M
-$215.96 M-22.59%
31 December 2023
Summary:
Relay Therapeutics annual working capital is currently $739.83 million, with the most recent change of -$215.96 million (-22.59%) on 31 December 2023. During the last 3 years, it has fallen by -$212.09 million (-22.28%). RLAY annual working capital is now -22.59% below its all-time high of $955.80 million, reached on 31 December 2022.RLAY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$818.16 M
+$158.93 M+24.11%
01 September 2024
Summary:
Relay Therapeutics quarterly working capital is currently $818.16 million, with the most recent change of +$158.93 million (+24.11%) on 01 September 2024. Over the past year, it has increased by +$78.33 million (+10.59%). RLAY quarterly working capital is now -19.46% below its all-time high of $1.02 billion, reached on 30 September 2022.RLAY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLAY Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +10.6% |
| 3 y3 years | -22.3% | -14.1% |
| 5 y5 years | +112.3% | +134.7% |
RLAY Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.6% | at low | -19.5% | +24.1% |
| 5 y | 5 years | -22.6% | +112.3% | -19.5% | +169.9% |
| alltime | all time | -22.6% | +112.3% | -19.5% | +169.9% |
Relay Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $818.16 M(+24.1%) |
| June 2024 | - | $659.23 M(-10.1%) |
| Mar 2024 | - | $732.96 M(-0.9%) |
| Dec 2023 | $739.83 M(-22.6%) | $739.83 M(-5.3%) |
| Sept 2023 | - | $781.05 M(-3.9%) |
| June 2023 | - | $812.77 M(-8.5%) |
| Mar 2023 | - | $887.92 M(-7.1%) |
| Dec 2022 | $955.80 M | $955.80 M(-5.9%) |
| Sept 2022 | - | $1.02 B(+25.1%) |
| June 2022 | - | $811.89 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $874.10 M(-8.2%) |
| Dec 2021 | $951.92 M(+25.8%) | $951.92 M(+55.9%) |
| Sept 2021 | - | $610.74 M(-6.9%) |
| June 2021 | - | $655.89 M(-9.7%) |
| Mar 2021 | - | $726.35 M(-4.0%) |
| Dec 2020 | $756.47 M(+117.0%) | $756.47 M(+7.1%) |
| Sept 2020 | - | $706.18 M(+133.0%) |
| June 2020 | - | $303.10 M(-7.3%) |
| Mar 2020 | - | $327.12 M(-6.1%) |
| Dec 2019 | $348.55 M(-16.5%) | $348.55 M |
| Dec 2018 | $417.24 M | - |
FAQ
- What is Relay Therapeutics annual working capital?
- What is the all time high annual working capital for Relay Therapeutics?
- What is Relay Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Relay Therapeutics?
- What is Relay Therapeutics quarterly working capital year-on-year change?
What is Relay Therapeutics annual working capital?
The current annual working capital of RLAY is $739.83 M
What is the all time high annual working capital for Relay Therapeutics?
Relay Therapeutics all-time high annual working capital is $955.80 M
What is Relay Therapeutics quarterly working capital?
The current quarterly working capital of RLAY is $818.16 M
What is the all time high quarterly working capital for Relay Therapeutics?
Relay Therapeutics all-time high quarterly working capital is $1.02 B
What is Relay Therapeutics quarterly working capital year-on-year change?
Over the past year, RLAY quarterly working capital has changed by +$78.33 M (+10.59%)